The Bioprocessing Technology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of bioprocessing technology has seen significant expansion in the recent past, and is expected to further grow from $25.1 billion in 2024 to $29.06 billion in 2025, witnessing a compound annual growth rate (CAGR) of 15.8%.
The Bioprocessing Technology Global Market is projected to reach $49.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.5%.
Download Your Free Sample of the 2025 Bioprocessing Technology Market Report and Uncover Key Trends Now!The key drivers in the bioprocessing technology market are:
• Continued expansion of biomanufacturing capacity
• Emergence and application of advanced therapies
• Increased use and significance of single-use bioprocessing systems
• Growing adoption and application of continuous bioprocessing
The bioprocessing technology market covered in this report is segmented –
1) By Product: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration
2) By Application: Antibiotics, Biosimilars, Recombinant Proteins, Other Applications
3) By End Use: Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed Industry, Contract Research Organization
The key trends in the bioprocessing technology market are:
• There is a shift towards personalized medicine and precision bioprocessing in the market.
• Regulatory compliance and quality assurance is a significant trend shaping the future.
• Expansion of biopharmaceutical production at a global scale is an emerging trend.
• The market is also being shaped by a focus on environmental sustainability and collaborative partnerships.
Major companies in the bioprocessing technology market are:
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Merck KGaA
• Danaher Corporation
• Lonza Group AG
• GE Healthcare
• Waters Corporation
• STADA Arzneimittel AG
• Bio-Rad Laboratories Inc.
• Applikon Biotechnology B.V.
• Agilent Technologies Inc.
• Solida Biotech GmbH
• Fujifilm Healthcare Corporation
• Catalent Inc.
• Asahi Kasei Medical Inc.
• Amgen Inc.
• Eppendorf AG
• Repligen Corporation
• Becton Dickinson and Company
• MilliporeSigma
• Novasep
• Boehringer Ingelheim GmbH
• Cytiva AB
• Wuxi Biologics
• AGC Biologics
• Samsung Biologics
• AbbVie Inc.
• Bristol Myers Squibb Company
• Pfizer Inc.
• Roche Holding AG
North America was the largest region in the bioprocessing technology market in 2023